Geode Capital Management, LLC Celldex Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,540,513 shares of CLDX stock, worth $42.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,540,513

Previous 1,533,956 0.43%

Holding current value

$42.5 Million

Previous $56.8 Million 7.82%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$32.06 - $44.56 $210,217 - $292,179	6,557 Added 0.43%	1,540,513 $52.3 Million
Q2 2024 Aug 09, 2024	BUY	$32.76 - $42.56 $3.92 Million - $5.09 Million	119,578 Added 8.45%	1,533,956 $56.8 Million
Q1 2024 May 13, 2024	BUY	$35.22 - $51.88 $10.4 Million - $15.4 Million	296,384 Added 26.51%	1,414,378 $59.4 Million
Q4 2023 Feb 13, 2024	BUY	$22.61 - $40.65 $2.66 Million - $4.78 Million	117,569 Added 11.75%	1,117,994 $44.3 Million
Q3 2023 Nov 13, 2023	BUY	$25.45 - $37.46 $899,708 - $1.32 Million	35,352 Added 3.66%	1,000,425 $27.5 Million
Q2 2023 Aug 11, 2023	BUY	$30.29 - $38.28 $1.19 Million - $1.51 Million	39,365 Added 4.25%	965,073 $32.7 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $1.47 Million - $2 Million	42,173 Added 4.77%	925,708 $33.3 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $856,429 - $1.4 Million	30,829 Added 3.62%	883,535 $39.4 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $262,911 - $435,135	11,582 Added 1.38%	852,706 $24 Million
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $294,974 - $537,141	-14,389 Reduced 1.68%	841,124 $22.7 Million
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $1.25 Million - $1.77 Million	45,093 Added 5.56%	855,513 $29.1 Million
Q4 2021 Feb 11, 2022	BUY	$35.68 - $56.27 $639,135 - $1.01 Million	17,913 Added 2.26%	810,420 $31.3 Million
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $3.46 Million - $6.69 Million	119,559 Added 17.77%	792,507 $42.8 Million
Q2 2021 Aug 13, 2021	BUY	$20.71 - $35.37 $6.63 Million - $11.3 Million	320,251 Added 90.8%	672,948 $22.5 Million
Q1 2021 May 12, 2021	BUY	$16.19 - $29.91 $868,480 - $1.6 Million	53,643 Added 17.94%	352,697 $7.27 Million
Q4 2020 Feb 12, 2021	BUY	$14.99 - $22.75 $620,960 - $942,418	41,425 Added 16.08%	299,054 $5.24 Million
Q3 2020 Nov 13, 2020	BUY	$9.65 - $15.19 $1.23 Million - $1.94 Million	127,392 Added 97.82%	257,629 $3.82 Million
Q2 2020 Aug 13, 2020	BUY	$1.61 - $13.41 $42,268 - $352,066	26,254 Added 25.25%	130,237 $1.69 Million
Q4 2019 Feb 13, 2020	BUY	$2.11 - $2.8 $1,666 - $2,212	790 Added 0.77%	103,983 $231,000
Q2 2019 Aug 14, 2019	SELL	$2.43 - $5.09 $12,422 - $26,020	-5,112 Reduced 4.72%	103,193 $276,000
Q1 2019 May 14, 2019	BUY	$3.45 - $10.35 $373,652 - $1.12 Million	108,305 New	108,305 $532,000

Others Institutions Holding CLDX

# of Institutions

206

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.29B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Celldex Therapeutics, Inc. Transaction History